Home » Threats » Page 101
Threats
Merck & Co. officials said the firm has provided 500,000 personal protective masks to New York City as part of efforts to address the COVID-19 outbreak.
“COVID-19 is a generational challenge to the global community,” Merck Chairman and CEO Kenneth C. Frazier said. “At Merck, we embrace our... Read More »
The global medicines company Novartis has committed to donating up to 130 million doses of generic hydroxychloroquine to support the COVID-19 pandemic response.
Hydroxychloroquine, in addition to chloroquine, is currently under evaluation in clinical trials for COVID-19 treatment. Novartis is... Read More »
Heads of various medical and infectious disease associations called on President Donald Trump to swiftly invoke the Defense Production Act and use it to force private industry to meet the current demands for medical supply and equipment production.
As one, the presidents and chairs of the... Read More »
The National Institutes of Health (NIH) intends to launch an education-packed website in the days ahead to train high-risk occupations still working amidst the outbreak of COVID-19.
The training is meant to help workers, such as hospital employees, food processing and delivery workers,... Read More »
U.S. Sens. Gary Peters (D-MI) and Patty Murray (D-WA) are calling on the Trump Administration to report to Congress on the federal government’s COVID-19 response.
Specifically, they are seeking information about nationwide testing capacity, hospital bed space, personal protective equipment... Read More »
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) will provide additional support for the development of Kevzara as a potential treatment for COVID-19.
Kevzara -- developed under a collaboration between Regeneron and Sanofi... Read More »
A group of lawmakers recently urged President Donald Trump to immediately implement all Defense Production Act (DPA) powers to expedite the production of needed materials during the coronavirus emergency.
Sens. Edward J. Markey (D-MA) and Sherrod Brown (D-OH) recently joined 18 of their... Read More »
A joint effort between the Department of Health and Human Services (HHS) and the Department of Defense (DoD) last week yielded 500,000 swabs and sample kits for COVID-19 testing that otherwise would have been stranded in Italy.
The supplies, produced by the Italian company Copan Diagnostics,... Read More »
A new diagnostic developed by Cepheid gained advanced development support from the U.S. Departments of Health and Human Services (HHS) and Defense (DoD) this week, pledging potential COVID-19 testing times of just 45 minutes.
Developed for use on another Cepheid product, the GeneXpert diagnostic... Read More »
Everlywell announced that an at-home test kit for COVID-19 would be available, starting Monday, March 23.
The initial supply of 30,000 tests is a significant increase in total COVID-19 tests that have been processed in the United States to date. The company plans to have testing and diagnosis... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) will invest $4.9 million in a consortium working to develop a COVID-19 vaccine candidate.
The investment and partnership include the Institut Pasteur in Paris, Themis Bioscience, an Austrian biotechnology company, and the University of... Read More »
The Food and Drug Administration (FDA) issued Friday two guidelines regarding the temporary manufacturing of certain alcohol-based hand sanitizer products in the wake of the COVID-19 pandemic.
“We are aware of significant supply disruptions for alcohol-based hand sanitizers,” FDA... Read More »
A new novel coronavirus test developed by the Georgia Esoteric and Molecular (GEM) Laboratory at the Georgia Department of Pathology promises diagnosis turnaround capabilities of just two hours.
At this time, the test is meant for patients of the Augusta University Health System. That said, Dr.... Read More »
While the preparations for COVID-19’s rapid spread through the United States have been widely noted as lacking, public health experts now are calling for public health officials -- not healthcare providers or politicians -- to take charge of the crisis and guide both the response to it and... Read More »
The U.S. Food and Drug Administration (FDA) has authorized the drug chloroquine to be tested as a potential COVID-19 treatment, as part of ongoing efforts to find countermeasures, but the data does not say whether it will work yet, experts warn.
Chloroquine, a malaria, lupus and arthritis... Read More »
A delegation of federal lawmakers representing the state of Washington is seeking a Centers for Medicare & Medicaid Services (CMMS) national emergency waiver to aid in addressing COVID-19.
The Senate and House of Representatives members have forwarded correspondence to CMMS Administrator Seema... Read More »
Air Force Chief of Staff Gen. David L. Goldfein recently provided insight into the branch’s COVID-19 protection efforts while also focusing on mission fulfillment and obligations.
Goldfein indicated as of March 18, there have been seven confirmed coronavirus cases among active-duty personnel,... Read More »
In the expanding efforts to find a solution to testing efforts against COVID-19, the Biomedical Advanced Research and Development Authority (BARDA) has provided $561,330 to Mesa Biotech, Inc. for development of a new diagnostic test.
This funding -- along with technical expertise -- will help... Read More »
Expanding its efforts to bring COVID-19 vaccines to fruition, the Coalition for Epidemic Preparedness Innovations (CEPI) invested $620,000 into the development of a new vaccine candidate designed by the University of Hong Kong.
“I'm thankful for the support from CEPI,” HKU President Xiang... Read More »
The USNS Comfort, a U.S. Navy ship, will be deployed to New York harbor to serve as a 1,000-bed hospital ship that will be used to treat coronavirus patients.
The ship, due to arrive in April, will also have 12 fully-equipped operating rooms and increase New York's hospital surge... Read More »
Emergent BioSolutions has struck an agreement with Vaxart, a clinical-stage biotechnology company, to develop and manufacture Vaxart’s experimental oral vaccine candidate for the COVID-19 coronavirus.
As part of the deal, Emergent will utilize its molecule-to-market contract development and... Read More »
Listen to Homeland Preparedness News' discussion with Greg Burel, the former director of the Strategic National Stockpile (SNS). The SNS' massive inventory of critical medical products and drugs are essential in dispatching lifesaving supplies to the nation's emergency responders on the front lines... Read More »
Emergent BioSolutions Inc., world-renowned as a bioterrorism expert, is also utilizing its contract development and manufacturing organization (CDMO) status to help quash the coronavirus disease COVID-19.
“For 22 years, Emergent has focused on products and services that address serious public... Read More »
The World Bank and the International Finance Committee (IFC) approved a $14 billion financing package to assist companies and countries in their efforts to respond to the spread of COVID-19.
About $8 billion of that is from IFC, which is a member of the World Bank Group. It will increase its... Read More »
The measures announced by the Trump administration to control the spread of the COVID-19 coronavirus have been endorsed by the Infectious Diseases Society of America (IDSA) and its HIV Medicine Association.
IDSA officials said an “all-sector, all-society response” is essential to reducing... Read More »
Sen. Bob Menendez (D-NJ) is urging President Donald Trump to invoke the Defense Production Act (DPA) as a means of accelerating COVID-19 national response, supply production and readiness.
“In the midst of a pandemic, state and local governments should not be left on their own scrambling to... Read More »
Senate lawmakers are urging the Federal Emergency Management Agency (FEMA) to galvanize Department of Agriculture (USDA) and Department of the Interior (DOI) efforts to enhance rural COVID-19 response coordination.
Sens. Tom Carper (D-DE) and Michael Bennet (D-CO) joined 22 other legislators in... Read More »
Looking for solutions to the nationwide shortages of coronavirus testing, despite the ongoing pandemic, U.S. Sen. Gary Peters (D-MI) proposed legislation this week that would make testing free and rapidly distributed both to communities and health care providers.
Calling on both the Trump... Read More »
The virus responsible for COVID-19, SARS-CoV-2, can remain stable for hours or even days in aerosols and on surfaces, according to a new study published by the National Institutes of Health, Centers for Disease Control and Prevention, UCLA and Princeton University.
Coronaviruses are known for... Read More »
Federal legislators are urging the United States Department of Agriculture (USDA) to take all the necessary steps to ensure there are no disruptions to our nation’s food supply chain during the COVID-19 coronavirus pandemic.
“We encourage you to use all of your available authorities to... Read More »
Reps. Peter DeFazio (D-OR), Bennie G. Thompson (D-MS) and Lou Correa (D-CA) are urging Acting Secretary of Homeland Security Chad Wolf to delay the Oct. 1, 2020, REAL ID Act implementation deadline.
The three legislators encouraged the delayed action, citing the impact of COVID-19, the limited... Read More »
A Senate decision to go on recess amid the novel coronavirus outbreak has drawn the ire of House members, several of which have called on their legislative counterparts to immediately vote on the Families First Coronavirus Act (H.R. 6201).
That act was voted through the House last week and has... Read More »
The first participant in the National Institute of Allergy and Infectious Diseases-funded (NIAID), Phase 1 clinical trial of a COVID-19 vaccine received their first dose this week, officially beginning an approximately six-week program.
The investigational vaccine, mRNA-1273, will be tested on... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) is looking to invest up to $2 billion to develop a COVID-19 vaccine.
The $2 billion funding call will enable CEPI to expand the number of vaccine candidates to increase the chances of success and fund clinical trials for these... Read More »
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) announced that two tests to detect the COVID-19 coronavirus are in development.
The tests would be able to produce results in approximately one hour.
The Biomedical... Read More »
